MolecuLight Secures $27.5 Million From Hayfin, a Leading Healthcare Institutional Investor
January 7, 2025
MolecuLight, a global medical device company pioneering point-of-care fluorescence imaging for measuring bacterial load in wounds, today announced it has secured a $27.5 million investment from Hayfin Capital
